Comprehensive historical analysis of global market for Xerostomia therapeutics has thoroughly analyzed in this report. It offers data and insights from 2019-2022, and provides extensive market forecasts from 2023-2032 by region/country and subsectors. It covers the price, sales volume, revenue, historical growth, gross margin, and future outlooks for the Xerostomia therapeutics market.

The Global Xerostomia Therapeutics Market Size is expected to grow from USD 1.85 billion in 2025 to USD 2.83 billion by 2035, at a CAGR of 4.34% during the forecast period 2025-2035.

The report includes growth prospects in the global Xerostomia therapeutics market by type, application, sub segement and region and QMI has compiled a comprehensive detailed research report to offer insights. The report details consumption in the Healthcare and other sectors. Regional coverage spans North America, Europe, and rest of the world including Asia Pacific.

Leading players of Xerostomia therapeutics including:

1. GlaxoSmithKline plc
2. Colgate?Palmolive Company
3. Church & Dwight Co., Inc.
4. Hikma Pharmaceuticals PLC
5. Sun Pharmaceutical Industries Ltd.
6. Lupin Pharmaceuticals, Inc.
7. Parnell Pharmaceuticals Inc.
8. Pendopharm
9. Pfizer Inc.
10. Acacia Pharma Group Plc

Request To Download Free Sample copy of the report @ https://www.sphericalinsights.com/request-sample/4653

Market split by Segement, can be divided into:

 By Therapeutic Modality

• Artificial Saliva and Saliva Substitutes
• Salivary Stimulants
• Electro-stimulation Devices
• Other

By Product Form

• Sprays
• Gels
• Lozenges and Pastilles
• Mouthwashes and Rinses
• Other

Market segment by Region/Country including:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

Check discount for this report: https://www.sphericalinsights.com/request-discount/4653

In November 2025, Aquoral partnered with Dentulu to expand delivery of advanced xerostomia therapies through a telehealth network, improving patient access to saliva substitutes, gels, sprays, and lozenges via direct-to-home services, reflecting the growing role of digital distribution in the market.

In March 2025, researchers in Australia introduced a citrus-oil-based mouthwash that significantly alleviated dry mouth symptoms in cancer patients undergoing radiation therapy, highlighting formulation innovation focused on enhanced therapeutic efficacy and patient comfort within the evolving xerostomia therapeutics market.

In March 2025, Ribox Therapeutics administered the first patient in a Phase I/IIa clinical trial of RXRG001, a circular RNA therapy for radiation-induced xerostomia, marking a pioneering advancement in biologic interventions and showcasing the potential for next-generation therapeutic approaches.

In February 2025, Saliwell showcased three new electro-stimulation device innovations for treating radiation-induced xerostomia at an international oral health forum, emphasizing technological advancement and diversification of treatment modalities in the global xerostomia therapeutics market.

Access full Report with Table of Content @ https://www.decisionsadvisors.com/reports/xerostomia-therapeutics-market

Whats covered in the report?

• 1. Overview of the Xerostomia therapeutics market.
• 2. The current and forecasted regional (North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa) market size data for the Xerostomia therapeutics market, based on segement.
• 3. Xerostomia therapeutics Market trends.
• 4. Xerostomia therapeutics Market drivers.
• 5. Analysis of major company profiles.

Reasons to buy this Market Report:

1. Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Xerostomia therapeutics market.

2. Use the SWOT analysis to determine the competitive intensity and therefore attractiveness of the emerging Xerostomia therapeutics Industry.

3. Leading company profiles reveal details of key Xerostomia therapeutics market players emerging five operations and financial performance.

4. Add weight to presentations and pitches by understanding the future growth prospects of the emerging Xerostomia therapeutics market with five year historical forecasts.

5. Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region.

6. Extensive information on factors that will amplify the growth of the Xerostomia therapeutics market over the upcoming seven years

7. Accurate estimation of the global Xerostomia therapeutics market size

8. Exact estimations of the upcoming trends and changes observed in the consumer behavior

9. Growth of the global Xerostomia therapeutics market across the North & South America, EMEA, Asia Pacific, and Latin America

10. Information about Xerostomia therapeutics market growth potential

11. In-depth analysis of the industry’s competitive landscape and detailed information vis-a-vis on various vendors

12. Furnishing of detailed information on the factors that will restrain the growth of the Xerostomia therapeutics market

About the Spherical Insights

Spherical Insights is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.

Contact Us:

Company Name: Spherical Insights

Email: [email protected]

Phone: +1 303 800 4326 (US)

Follow Us: LinkedIn | Facebook | Twitter